James Shapiro
University of Alberta · Clinical Islet Transplant Program, University of Alberta
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name James Shapiro as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 21:39 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT05349591 · cePolyTregs in Islet TransplantationUniversity of Alberta · withdrawn · Diabetes type1 · principal investigator
- Ph1NCT05073302 · Device-Less Technique in Islet TransplantationUniversity of Alberta · completed · Type 1 Diabetes · principal investigator
- Ph1NCT03444064 · PolyTreg Immunotherapy in Islet TransplantationUniversity of Alberta · completed · Diabetes, Diabetes Mellitus, Type 1 · principal investigator
- Ph1/Ph2NCT03182426 · Stem Cell Mobilization (Plerixafor) and Immunologic Reset in Type 1 Diabetes (T1DM)University of Alberta · completed · Diabetes Mellitus, Type 1 · principal investigator
- Ph1/Ph2NCT03089840 · Normothermic Liver Preservation TrialUniversity of Alberta · completed · End Stage Liver Disease, Liver Diseases · principal investigator
- Ph1NCT03073577 · Islet Transplantation Using PKX-001University of Alberta · completed · Type 1 Diabetes Mellitus · principal investigator
- Ph1/Ph2NCT02821026 · Omental Islet TransplantUniversity of Alberta · completed · Type 1 Diabetes · principal investigator
- Ph1/Ph2NCT02520076 · Aralast NP in Islet TransplantUniversity of Alberta · completed · Type 1 Diabetes Mellitus · principal investigator
- Ph1NCT02457858 · Islet Isolation Using MnTE-2-PyP (BMX-010) - Pilot StudyUniversity of Alberta · completed · Type 1 Diabetes · principal investigator
- Ph1/Ph2NCT01653899 · Caspase Inhibition in Islet TransplantationUniversity of Alberta · completed · Diabetes · principal investigator
- Ph1/Ph2NCT01652911 · A Phase I/II Study of the Safety and Efficacy of Sernova's Cell PouchTM for Therapeutic Islet TransplantationUniversity of Alberta · terminated · Type I Diabetes · principal investigator
- Ph2NCT00769873 · Anticoagulation Post Laparoscopic SplenectomyUniversity of Alberta · terminated · Portal Vein Thrombosis, Splenic Vein Thrombosis · principal investigator
- Ph2NCT00468403 · LEA29Y (Belatacept) Emory Edmonton ProtocolNational Institute of Allergy and Infectious Diseases (NIAID) · completed · Type 1 Diabetes Mellitus · study chair
- Ph3NCT00434811 · Islet Transplantation in Type 1 DiabetesNational Institute of Allergy and Infectious Diseases (NIAID) · completed · Type 1 Diabetes Mellitus · study chair
- Ph2NCT00175266 · Islet Transplantation Using Campath-1H and Infliximab InductionUniversity of Alberta · completed · Type 1 Diabetes · principal investigator
- Ph2NCT00175253 · Alemtuzumab Induction in Islet TransplantationUniversity of Alberta · completed · Type 1 Diabetes · principal investigator
- Ph2NCT00014911 · Islet Transplantation for Type 1 DiabetesNational Institute of Allergy and Infectious Diseases (NIAID) · completed · Diabetes Mellitus, Insulin-Dependent · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 21:39 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 21:39 UTC. The ranking covers the 200 most relevant of 155 PubMed records, and a shared surname and initials can bring in a namesake. All 155 on PubMed
- K-ras mutations and benefit from cetuximab in advanced colorectal cancer.N Engl J Med · 20082,963 citationsRCR 65.1
- Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.Lancet Oncol · 20152,153 citationsRCR 80.0
- Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer.N Engl J Med · 2022898 citationsRCR 60.5
- Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial.J Clin Oncol · 2021700 citationsRCR 43.3
- Stenting and medical therapy for atherosclerotic renal-artery stenosis.N Engl J Med · 2014684 citationsRCR 23.8
- 542 citationsRCR 20.1
- Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group.J Am Acad Dermatol · 1998508 citationsRCR 16.7
- 317 citationsRCR 18.3
- Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index.Arch Dermatol · 2004305 citationsRCR 10.4
- The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin.Am Rev Respir Dis · 1993302 citationsRCR 9.9